Side-by-side comparison of AI visibility scores, market position, and capabilities
Baltimore NASDAQ-listed Latin American university operator (LAUR) with 470,000+ students in Mexico/Peru; 2024 revenue $1.54B with 2025 guidance $1.68-1.69B (+7-8%); $150M additional buyback authorized competing for private higher education enrollment.
Laureate Education is a Baltimore, Maryland-based international for-profit higher education company — publicly traded on NASDAQ (NASDAQ: LAUR) — operating five university institutions in Mexico and Peru that collectively serve 470,000+ enrolled students (with projections of 494,000 for 2025, +5% year-over-year) through campus-based and online degree programs. In full-year 2024, Laureate generated $1.54 billion in revenue, with 2025 guidance raised to $1.68-1.69 billion (+7-8% year-over-year) and adjusted EBITDA of $508-512 million based on Q3 2025 results. In Q3 2025, Laureate reported $400.2 million quarterly revenue (+9% year-over-year) and authorized an additional $150 million share buyback (adding to $102 million repurchased in 2024). Laureate's five institutions are Universidad del Valle de México (UVM), Universidad Tecnológica de México (UNITEC), and ICEL Universidad in Mexico, and Universidad Privada del Norte (UPN) and Universidad Peruana de Ciencias Aplicadas (UPC) in Peru. CEO Eilif Serck-Hanssen has led the company since 2018. Founded 1989 as Sylvan Learning Systems by Doug Becker; at peak operated 71 institutions across 25 countries before strategic divestiture to current two-country focus.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.